{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:29:42Z","timestamp":1794475782566,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-2-0010"],"award-info":[{"award-number":["W81XWH-16-2-0010"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["OC220389"],"award-info":[{"award-number":["OC220389"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ygyno.2026.04.018","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:44:54Z","timestamp":1778161494000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis"],"prefix":"10.1016","volume":"209","author":[{"given":"Alexandra","family":"Lukey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salmanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Grout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy McKinnon","family":"Deurloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste Leigh","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2026.04.018_bb0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ygyno.2020.03.028","article-title":"Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis","volume":"157","author":"Majidi","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.04.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.04.018_bb0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2018.01.030","article-title":"Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US","volume":"149","author":"Liao","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.018_bb0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/CCO.0b013e32832efc5b","article-title":"Managing menopausal symptoms after gynecological cancer","volume":"21","author":"Michaelson-Cohen","year":"2009","journal-title":"Curr. Opin. Oncol."},{"issue":"10430","key":"10.1016\/j.ygyno.2026.04.018_bb0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ygyno.2026.04.018_bb0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.018_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2021.10.001","article-title":"Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study","volume":"163","author":"Gernier","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.04.018_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009734.2018.1544597","article-title":"Gynecologists are afraid of prescribing hormone replacement to endometrial\/ovarian cancer survivors despite national guidelines\u2014a survey in Sweden","volume":"123","author":"Halldorsdottir","year":"2018","journal-title":"Ups. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.ygyno.2026.04.018_bb0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0000000000001396","article-title":"Hormone use after nonserous epithelial ovarian Cancer: overall and disease-free survival","volume":"127","author":"Power","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.018_bb0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2022.09.027","article-title":"Hormone replacement in premenopausal women treated with bilateral oophorectomy for ovarian cancer \u2013 a nationwide population-based study","volume":"167","author":"Von Kartaschew","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.04.018_bb0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ygyno.2020.06.481","article-title":"Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival","volume":"158","author":"Brieger","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.04.018_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/13697137.2013.806472","article-title":"The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China","volume":"16","author":"Wen","year":"2013","journal-title":"Climacteric"},{"issue":"6771","key":"10.1016\/j.ygyno.2026.04.018_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.302.6771.259","article-title":"Hormone replacement therapy and survival after surgery for ovarian cancer","volume":"302","author":"Eeles","year":"1991","journal-title":"BMJ"},{"issue":"35","key":"10.1016\/j.ygyno.2026.04.018_bb0070","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"JCO"},{"issue":"6","key":"10.1016\/j.ygyno.2026.04.018_bb0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.018_bb0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3892\/ol.2011.461","article-title":"Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy","volume":"3","author":"Li","year":"2012","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.ygyno.2026.04.018_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.122.061559","article-title":"Rethinking menopausal hormone therapy: for whom, what, when, and how long?","volume":"147","author":"Cho","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ygyno.2026.04.018_bb0090","series-title":"BC Cancer Data Extract","volume":"V2","author":"Population Data BC","year":"2023"},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.018_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.018_bb0100","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2018.29.e15","article-title":"Trends of low-grade serous ovarian carcinoma in the United States","volume":"29","author":"Matsuo","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2026.04.018_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.41743","article-title":"Association of vaginal estradiol tablet with serum estrogen levels in women who are postmenopausal: secondary analysis of a randomized clinical trial","volume":"5","author":"Mitchell","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.04.018_bb0110","author":"SAS Health Users Group"},{"key":"10.1016\/j.ygyno.2026.04.018_bb0115","unstructured":"Duchesneau ED, Jackson BE, Webster-Clark M, Lund JL, Reeder-Hayes KE. The timing, the treatment, the question: comparison of epidemiologic approaches to minimize immortal time bias in real-world data using a surgical oncology example. Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.04.018_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.5547","article-title":"Core concepts in pharmacoepidemiology: key biases arising in pharmacoepidemiologic studies","volume":"32","author":"Acton","year":"2023","journal-title":"Pharmacoepidemiol. Drug."},{"key":"10.1016\/j.ygyno.2026.04.018_bb0125","author":"Aragon"},{"key":"10.1016\/j.ygyno.2026.04.018_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/aogs.13120","article-title":"Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy","volume":"96","author":"Johansen","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:00:10Z","timestamp":1794474010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826019724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S0090825826019724"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.04.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}